Loss of nuclear factor-κB is tumor promoting but does not substitute for loss of p53

Cancer Research

Volumn 64, Issue 13, 2004, Pages 4415-4418

  Ryan, Kevin M ^a,b   O'Prey, Jim ^a   Vousden, Karen H ^a,b  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

E1A PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P53; PROTEIN SUBUNIT; RAS PROTEIN; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL DEATH; EMBRYO; GENE EXPRESSION; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION;

ADENOVIRUS E1A PROTEINS; ANIMALS; APOPTOSIS; CARRIER PROTEINS; CELL ADHESION; CELL DIVISION; CELLS, CULTURED; FIBROBLASTS; MICE; MICE, NUDE; NEOPLASM PROTEINS; NF-KAPPA B; RAS PROTEINS; RETROVIRIDAE; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 3042780178     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1474     Document Type: Article

References (20)

1. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature (Lond.) 2000; 408:307-10.
2. Fridman JS, Lowe SW. Control of apoptosis by p53. Oncogene 2003;22:9030-40.
3. Schmitt CA. Senescence, apoptosis and therapy: cutting the lifelines of cancer. Nat Rev Cancer 2003;3:286-95.
4. Vousden KH. p53: death star. Cell 2000;103:691-4.
5. Ryan KM, Ernst MK, Rice NR, Vousden KH. Role of NF-kappaB in p53-mediated programmed cell death. Nature (Lond) 2000;404:892-7.
6. Kucharczak J, Simmons MJ, Fan Y, Gelinas C. To be, or not to be: NF-kappaB is the answer-role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene 2003;22:8961-82.
7. Tergaonkar V, Pando M, Vafa O, Wahl G, Verma I. p53 stabilization is decreased upon NFkappaB activation: a role for NFkappaB in acquisition of resistance to chemotherapy. Cancer Cell 2002;1:493-503.
8. Ouaaz F, Li M, Beg AA. A critical role for the RelA subunit of nuclear factor kappaB in regulation of multiple immune-response genes and in Fas-induced cell death. J Exp Med 1999;189:999-1004.
9. Lin KI, Lee SH, Narayanan R, Baraban JM, Hardwick JM, Ratan RR. Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B. J Cell Biol 1995;131:1149-61.
10. Fujioka S, Sclabas GM, Schmidt C, et al. Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesis. Oncogene 2003;22:1365-70.
11. Dajee M, Lazarov M, Zhang JY, et al. NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature (Lond) 2003;421:639-43.
12. Rayet B, Gelinas C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene 1999;18:6938-47.
13. Deng J, Miller SA, Wang HY, et al. beta-Catenin interacts with and inhibits NF-kappa B in human colon and breast cancer. Cancer Cell 2002;2:323-34.
14. Higashitsuji H, Nagao T, Nonoguchi K, Fujii S, Itoh K, Fujita J. A novel protein overexpressed in hepatoma accelerates export of NF-kappa B from the nucleus and inhibits p53-dependent apoptosis. Cancer Cell 2002;2:335-46.
15. Lowe SW, Jacks T, Housman DE, Ruley HE. Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc Natl Acad Sci USA 1994;91:2026-30.
16. Soengas MS, Alarcon RM, Yoshida H, et al. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science (Wash DC) 1999;284:156-9.
17. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
18. Liu G, Parant JM, Lang G, et al. Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice. Nat Genet 2004; 36:63-8.
19. Wang CY, Cusack JC Jr, Liu R, Baldwin AS Jr. Control of inducible chemoresistance: enhanced antitumor therapy through increased apoptosis by inhibition of NF-kappaB. Nat Med 1999;5:412-7.
20. Wang CY, Mayo MW, Baldwin AS Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science (Wash DC) 1996;274:784-7.